Demonstration of alpha1-antitrypsin in paraffin sections of hepatoma and cirrhosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Virchows Archiv

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00442386PMID 6294975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency.

  2009cited by this paper
• PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

  2009cited by this paper
• Pathology of Hepatocellular Carcinoma

  2006cited by this paper
• Pathology of hepatocellular carcinoma

  1993cited by this paper
• Expression of protein markers in malignant hepatoma. Evidence for genetic and epigenetic mechanisms

  1980cited by this paper
• Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma?

  1979cited by this paper
• Alpha-1-antitrypsin deficiency and hepatocellular carcinoma.

  1979cited by this paper
• Serum trypsin inhibitory capacity and alpha 1-antitrypsin levels in liver cirrhosis and hepatoma.

  1979cited by this paper
• Demonstration of alpha 1-antitrypsin in hepatomas.

  1979cited by this paper
• Distribution of five antigens in hepatocellular carcinoma.

  1979cited by this paper
• Alpha-1-antitrypsin globules in the liver and PiM phenotype.

  1978cited by this paper
• Periodic Acid Schiff‐Positive Non‐Glycogenic Globules in Hepatocytes

  1978cited by this paper
• Alpha-1-antitrypsin bodies in the liver.

  1977cited by this paper
• Alpha-1-antitrypsin globules in the liver and PiM phenotype.

  1977cited by this paper
• Alpha1-antitrypsin, protein marker in oral contraceptive-associated hepatic tumors.

  1977cited by this paper
• Pathology and Pathogenesis

  1977cited by this paper
• Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma.

  1976cited by this paper
• Alpha-antitrypsin deposition in primary hepatic carcinomas.

  1976cited by this paper
• Intracytoplasmic hyaline globules in hepatocellular carcinomas

  1976cited by this paper
• Alpha1-antitrypsin and alpha-fetoprotein. Protein markers in endodermal sinus (yolk sac) tumors.

  1976cited by this paper
• Alpha-l-antitrypsin Deficiency and Liver Disease in Adults

  1976cited by this paper
• Alpha-antitrypsin deposition in primary hepatic carcinomas.

  1976cited by this paper
• Alpha-1-antitrypsin deficiency and liver in adults.

  1976cited by this paper
• Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).

  1975cited by this paper
• Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency.

  1974cited by this paper
• Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency.

  1974cited by this paper
• Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals.

  1974cited by this paper
• Alpha-1-antitrypsin deficiency; a hereditary enigma.

  1974cited by this paper
• Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).

  1974cited by this paper
• Hyaline globules in human neoplasms. A report of three autopsy cases.

  1973cited by this paper
• Liver disease in adults with alpha-1 -antitrypsin deficiency.

  1972cited by this paper
• THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES

  1970cited by this paper
• Cytoplasmic hyaline inclusions in hepatoma. Histochemical study.

  1968cited by this paper
• Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency.

  1967cited by this paper
• Obstructive Lung Disease and Trypsin Inhibitors in α1-Antitrypsin Deficiency

  1967cited by this paper

• Immunohistochemistry of Hepatocellular Carcinoma

  2016cites this paper
• Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma

  2012cites this paper
• Is heterozygous alpha‐1‐antitrypsin deficiency type PiZ a risk factor for primary liver carcinoma?

  2000cites this paper
• Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma.

  1992cites this paper
• Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature.

  1988cites this paper
• [Biological markers of hepatocellular carcinoma].

  1987cites this paper
• Tissue Antigen Distribution in Hepatocellular Carcinoma

  1986cites this paper
• Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.

  1986cites this paper
• [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype].

  1985cites this paper
• Fibrolamellár hepatocellular carcinoma. An immunohistochemical and ultrastructural study

  1985cites this paper
• Comparison of alpha-1-antitrypsin and alpha-1-antichymotrypsin in hepatocellular carcinoma: an immunoperoxidase study.

  1984cites this paper
• Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.

  1984cites this paper